What is a primary requirement of the Poison Prevention Packaging Act of 1970?

The Poison Prevention Packaging Act of 1970 was established primarily to reduce the risk of children accidentally ingesting potentially dangerous substances, particularly prescription and over-the-counter medications. The act mandates that certain medications and household substances must be packaged in child-resistant packaging. This requirement directly addresses safety concerns by making it more difficult for young children to open these packages, thereby preventing accidental poisonings.

Child-proof packaging for controlled drugs is a key aspect of this legislation, as it ensures that medications that could be harmful if ingested by a child are not easily accessible. This requirement reflects the law's intent to safeguard children while still allowing adults to use the medications as prescribed.

The other options do not accurately represent the main focus of the Act. Mandatory medical consultations are not required by this legislation; instead, patient counseling can be part of good pharmaceutical practice but is not a primary objective of this law. Online descriptions of medications are not addressed by the Act and focus more on information accessibility than safety. Similarly, while tracking prescription drug sales may be important for monitoring usage patterns and preventing abuse, it is not a mandate of the Poison Prevention Packaging Act, which is primarily concerned with packaging and safety.